Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. [PDF]
Gilabert-Oriol R +5 more
europepmc +1 more source
Common pharmacophore of structurally distinct small-molecule inhibitors of intracellular retrograde trafficking of ribosome inactivating proteins. [PDF]
Yu S +4 more
europepmc +1 more source
A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L. [PDF]
Meng Y +5 more
europepmc +1 more source
Chemical structure of Retro-2, a compound that protects cells against ribosome-inactivating proteins. [PDF]
Park JG, Kahn JN, Tumer NE, Pang YP.
europepmc +1 more source
Effects of Sodin 5 on the Proliferation and Migration of Human Glioblastoma Cells. [PDF]
Russo V +6 more
europepmc +1 more source
MAP30, a type Ⅰ ribosome-inactivating protein, inhibits hepatocellular carcinoma by inducing apoptosis through mitochondria. [PDF]
Yang D +6 more
europepmc +1 more source
Tetracyclines, a timely resurgence or doomed to fail again? [PDF]
Fenn S, Panagiotopoulou D, Hardie KR.
europepmc +1 more source
Plant-Derived Anti-TMV Metabolites: Mechanisms, Limitations and Future Perspectives. [PDF]
Aslam MQ +8 more
europepmc +1 more source
A liquid handling platform for standardized quantification of cell-free enzymatic activity encoded by antimicrobial resistance genes. [PDF]
Bergum M +4 more
europepmc +1 more source

